Friday, November 9, 2018

Home Automation – The next generation Smart Homes

The Smart Home market in India has been witnessing tremendous growth in terms of value as well as volume. Home automation has been considered as a business of rich people a few years back and it was all true as the cost of automation was not at all suitable to the pockets of large population in the country. However, even for the people who could have easily afforded the automation solutions, adoption ratio was negligible. The situation has turned around completely and over the last few years, a trend of automation is taking place in the country. With the increasing need for comfort and ease along with rising disposable incomes of people living in metro cities, the market for smart homes has been on the growth path.

Smart Home Market in India by Aarkstore
Home Automation Market in India

According to "India Smart Home Market Outlook, 2021" the smart home market in India has grown significantly in the last three years starting from 2014 to 2017. The smart home market which consists of mainly three segments – Commercial, Hospitality and Residential – has seen a higher adoption ratio of automation in the hospitality sector. The reason is obvious that premium hotels need to provide sophisticated luxuries to their customers. Though the share of the commercial segment is very less, it has registered highest growth in the last few years. The residential market on other hand is moving in the upward direction with a standard pace. The other good thing that has happened to the market is the introduction of retrofit automation solutions. Previously, the major drawback for the residential segment was the high price of automation solutions which have now drastically come down with retrofit solutions being available at a price at as low as Rs. 3600.

Moreover, in the metro and tier-I cities, the new housing schemes are being developed with home automation systems enabled as per the customer’s requirement. Both the hospitality as well as the residential market for automation is likely to increase in the future. Control4, Crestron and Lutron GL are amongst the top manufacturers providing automation devices in India. The retrofit solutions are majorly being offered by the bunch of start-ups which have established in the last two years. Silvan Labs, Inoho and Pert are amongst the top automation startups in India. The residential smart home market is expected to grow robustly in the forecasted period, on a condition that awareness for the same should be brought amongst the citizens.

Key Segments

  • Residential Smart Home
  • New/Entire Home Automation
  • Retrofit Home Automation
  • Hospitality Smart Home 
  • Hotel Exterior & Lobby Market
  • Hotel Rooms
  • Commercial Smart Home

Key Categories

  • Lighting
  • Blinds
  • Hubs/Server
  • Entertainment (Audio/Video)
  • Security/Access
  • Energy Management
  • Others
This report can be useful to Industry consultants, manufacturers and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Report Methodology

The information contained in this report is based upon both primary and secondary research. Primary research included interviews with various channel partners of automation solution providers in India. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and proprietary databases.

Category:  Technology Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Friday, November 2, 2018

Thyroid Cancer Pipeline Review

Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, the report provides comprehensive insights about marketed and Phase III products for Thyroid Cancer. The report includes information on marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. 

Thyroid Cancer Drug Market Trends by Aarkstore Market Research
Thyroid Cancer Market Research by Aarkstore


Global API Manufacturers of Marketed Products for Thyroid Cancer 

Coverage of API manufacturers for Thyroid Cancer marketed products spanning across United States, Europe, China, and India. The manufacturers' details include manufacturers name along with their location.

Emerging Phase III products for Thyroid Cancer 

This report provides a comprehensive understanding of the emerging Phase III therapies for Thyroid Cancer which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Secondary information and data have been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations, and available databases.

Scope

  • A review of the marketed products for Thyroid Cancer including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
  • API manufacturers for the marketed products with location details
  • Emerging Phase III product profiles for Thyroid Cancer including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy 

  • API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
  • Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
  • Design effective counter-strategies to gain a competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
  • Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space


Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Thursday, November 1, 2018

Ageing market's current change

Ageing - Pipeline Insights, the report provides comprehensive insights into the ongoing therapeutic research and development across Ageing. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Ageing by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.


Ageing Pipeline Insight by Aarkstore
Global Ageing Pipeline Insight 2017 by Aarkstore Market research
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

The scope of the report
  • The report provides a snapshot of the pipeline development for the Ageing 
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Ageing 
  • The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ageing 
  • The report also covers the dormant and discontinued pipeline projects related to the Ageing 
Reasons to Buy

  • Establish a comprehensive understanding of the pipeline activity across this Ageing to formulate effective R&D strategies
  • Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage 
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Ageing therapeutics
  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Category: Healthcare Market Research

Contact Details:
Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Wednesday, October 31, 2018

Interstitial cystitis - An overview

Interstitial Cystitis - Pipeline Insights, 2017, the report provides comprehensive insights about pipeline drugs across this indication. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research for the treatment of Interstitial Cystitis. 

Pipeline Insights Interstitial Cystitis Market Research Reports by Aarkstore
Pipeline Insights – Interstitial Cystitis | Market Research Reports | Aarkstore

This report provides information on the therapeutic development for Interstitial Cystitis, dealing with all the pipeline drugs. Comparative analysis at various stages covering Phase III, Phase II, Phase I, Pre-Clinical, and Discovery stages, therapeutics assessment by monotherapy and combination products and molecule type drug information is also covered in this report. The report also covers marketed products [Cimzia and Humira, marketed for other indications] that are being investigated in Phase III trials to determine therapeutic efficacy for Interstitial Cystitis. The report covers financial information on companies involved in the therapeutic development for this indication. The report further contains details on dormant and discontinued products.


The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Related Reports :
  • Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018
  • Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2018
  • Interstitial Cystitis-Pipeline Insights, 2018


Contact Details:

+91 7710006788 | contact@aarkstore.com | aarkstore.com

Tuesday, October 30, 2018

Skin Diseases by Acinetobacter Infections

Acinetobacter Infections-Pipeline Insights, 2017. The report provides comprehensive insights into the ongoing therapeutic research and development across Acinetobacter Infections. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Acinetobacter Infections by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

Global Acinetobacter Infections Pipeline Insights
Global Acinetobacter Infections-Pipeline Insights 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

The scope of the report

  • The report provides a snapshot of the pipeline development for the Acinetobacter Infections 
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Acinetobacter Infections 
  • The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acinetobacter Infections 
  • The report also covers the dormant and discontinued pipeline projects related to the Acinetobacter Infections 

Reasons to Buy

  • Establish a comprehensive understanding of the pipeline activity across this Acinetobacter Infections to formulate effective R&D strategies
  • Gather information of the emerging competitors having the potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage 
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Acinetobacter Infections therapeutics
  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com

Monday, October 29, 2018

Acute Coronary Syndrome - A lookout!

The acute coronary syndrome is a term used to describe a range of conditions associated with sudden, reduced blood flow to the heart. Condition when cell death results in damaged or destroyed heart. This report provides comprehensive insights about marketed and Phase III products for Acute Coronary Syndrome. Also includes information on marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. 


Global Acute Coronary Syndrome(ACS) Market | API Manufacturers, Drugs and Forecast 2020
Global Acute Coronary Syndrome Market -  API Manufacturers, Drugs, and Forecast 2020 by Aarkstore

Global API Manufacturers of Marketed Products for Acute Coronary Syndrome - Coverage of API manufacturers for Acute Coronary Syndrome marketed products spanning across United States, Europe, China, and India. The manufacturer's details include manufacturers name along with their location.

Emerging Phase III products for Acute Coronary Syndrome - This report provides a comprehensive understanding of the emerging Phase III therapies for Acute Coronary Syndrome which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis. Secondary information and data have been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations, and available databases.

Scope
  • A review of the marketed products for Acute Coronary Syndrome including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
  • Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details.
API manufacturers for the marketed products with location details - Emerging Phase III product profiles for Acute Coronary Syndrome including product description, developmental activities, licensors & collaborators and chemical information

Reasons to Buy 
  • API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
  • Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
  • Design effective counter-strategies to gain a competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
  • Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space
Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com

Technology in Aerospace and Defense is blooming!


In the world of aerospace and defense, technological developments have always been a crucial aspect of staying ahead of rivals both for military and commercial players. Now though, perhaps more than ever, technology from other industries is starting to creep into the A&D world and could provide some highly useful new methods of production, learning, and protection of assets. The major military players and significant defense companies are experimenting with the potential of many of these developing technologies and they could lead to some significant leaps in capability.

3D Printing, Blockchain, Cybersecurity and Big Data Market
Aerospace and Defense Technology - 3d Printing, Blockchain, Cybersecurity, and Big Data Market 
This new technology does come with problems, however, and the changing nature of warfare between nations means that threats are increasingly coming from the internet and software rather than troops on the ground. This means players of all types need to be prepared for this technology whether they want to or not. These four technological areas include; 3D printing, the blockchain, cybersecurity, and big data all of which most A&D firms are now heavily involved in.

Key Highlights

The aerospace industry requires precision engineering to produce high specification parts. 3D printers have already proved their worth here: Airbus Group conducted a study to assess the effectiveness of 3D printing on a highly standardized part - an Airbus A320 nacelle hinge bracket. They compared EOS’s titanium printed bracket (using direct metal laser sintering) with a traditionally cast steel bracket. Airbus concluded that EOS’s 3D printed bracket was stronger, lighter and produced 40% less CO2 emissions during manufacture. Moreover, because the 3D printing process used only the material needed to make the part, it eliminated any waste from secondary machining, thereby reducing titanium consumption by 25%.

Blockchain technology often referred to as “distributed ledger technology” (or DLT) is a means by which the participants in a distributed network can each maintain a copy of an immutable ledger of transactions, and where transactions can be executed without the need for a single, central, coordinating authority. This has a wide variety of applications and many companies are very excited by the possibilities that this offers.

Cybersecurity has been a concern for aerospace and defense companies for decades, due to their roles as operators of critical military infrastructure and providers of essential hardware. However, concern over cybersecurity continues to climb up the defense agenda, driven by the increasingly interconnected nature of infrastructure, hardware and systems, and the growing number of attacks targeting defense-related and critical operational information. Military hardware is currently undergoing significant change. Services are becoming ever more integrated through information sharing.

Resultantly, companies working in aerospace and defense are racing to develop cybersecurity systems that can withstand complex and penetrative attacks from governments and independent actors. The transition has been rapid and will undergo further change as artificial intelligence and machine learning begins to play an ever-greater role in the modern battlefield. Given the potential for disruption - such as the grounding of aircraft fleets, collapse of communication systems or general confusion in the command chain - the need for cybersecurity that is reliable and able to withstand cutting-edge attacks will become elevated beyond current levels.

Scope

  • Examine the major trends in aerospace and defense technology
  • See how big data technology is becoming a big target for A&D firms
  • Explore the benefits of 3D Printing technology to A&D companies and militaries
  • Examine how cybersecurity has become such an important issue and how companies are trying to solve it
  • See how blockchain technology is being pursued by A&D companies

Reasons to buy

  • What technology absorbing the attention of modern military planners?
  • Where is the money going and is it being spent wisely?
  • Are all of the new technologies emerging actually practical?
  • What can we expect to see in future wars and does this make the world safer or less safe?

Category: Defense Market Research

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com